Another observational study was released supporting the notion that a heartburn drug helps improve clinical outcomes in coronavirus patients. Famotidine, which is used to treat heartburn and is ...

MANHASSET, New York (WABC) -- A heartburn drug commonly known as Pepcid has been shown to reduce COVID-19 symptoms and inflammation in the body, according to results published in a clinical trial on ...

Results from a fully remote randomized, outpatient clinical trial encourage the additional study of the active ingredient in common heartburn medication to help with COVID-19 treatment MANHASSET, N.Y.

More data from observational studies, this time in hospitalized patients, indicated that famotidine (Pepcid AC), which is used to treat heartburn, was associated with improved clinical outcomes in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There was no correlation observed between in-hospital ...

CLEVELAND, Ohio -- A newly published study reinforces the suggestion that famotidine, an active ingredient in the over-the-counter heartburn drug Pepcid, might help coronavirus patients avoid ...

Ibuprofen, famotidine 800mg/26.6mg; tabs. Ibuprofen has analgesic, antiinflammatory, and antipyretic properties. The mechanism of action of the ibuprofen, like that of other NSAIDs, is not completely ...

Pepcid products are commonly used to prevent and treat heartburn caused by acid indigestion and upset stomach. The main active ingredient in Pepcid is famotidine, which belongs to a class of medicines ...

Please provide your email address to receive an email when new articles are posted on . Famotidine use was associated with a lower risk for adverse outcomes among patients hospitalized with COVID-19, ...

Description The goal of the trial was to evaluate treatment with famotidine compared with placebo among patients taking low-dose aspirin. Hypothesis Famotidine would be more effective in preventing ...